Free tool
Drug Trial Radar: Gastroenterology and liver
Last checked: Nov 20, 2026Latest source record: Jul 23, 2025 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
2
Recruiting, industry sponsors, Gastroenterology and liver, Phase 4 (post-approval)
By trial status
The same filters, counted in each status. Pick one to switch.
2 trials
Showing 1 to 2, recently updated first.
- Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or PantoprazolePivotal-lookingRecruiting
Carnot LaboratoriesIndustry
NCT06991348 · 128 participants (planned) · Start Jul 30, 2024 · Primary completion Nov 30, 2025
Drug: Tegoprazan; Pantoprazole · For: Gastroesophageal Reflux Disease
Sites: Mexico City, Mexico; Boca del Río, Mexico
Getz PharmaIndustry
NCT05644717 · 164 participants (planned) · Start Mar 1, 2023 · Primary completion Nov 1, 2025
Drug: Ertugliflozin 5 mg, 15mg · For: Liver Fat; Liver Fibrosis; Glycemic Control and 3 more
Sites: Peshawar, Pakistan
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.